Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Feb 27, 2018, after the close
10-K filed Feb 27, 2018, 58 days after period end · 0001564590-18-003526
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $43.56M | $11.96M | $17.00K | $47.00K |
| Net Income | -$68.87M | -$78.70M | -$45.78M | -$28.37M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.55 |
| -$0.65 |
| -$0.45 |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
